homocysteine has been researched along with drospirenone in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beretta, L; Caronni, M; Scorza, R | 1 |
Battaglia, C; Busacchi, P; Cianciosi, A; Facchinetti, F; Mancini, F; Persico, N | 1 |
Bart, S; Diefenbach, K; Marr, J; Sampson-Landers, C; Trummer, D | 1 |
Bodur, S; Dundar, O; Kanat-Pektas, M; Kinci, MF; Tutuncu, L | 1 |
2 trial(s) available for homocysteine and drospirenone
Article | Year |
---|---|
Folate status and homocysteine levels during a 24-week oral administration of a folate-containing oral contraceptive: a randomized, double-blind, active-controlled, parallel-group, US-based multicenter study.
Topics: Adolescent; Adult; Androstenes; Calcium; Contraceptives, Oral; Double-Blind Method; Estrogens; Ethinyl Estradiol; Female; Folic Acid; Glutamates; Homocysteine; Humans; Mineralocorticoid Receptor Antagonists; Neural Tube Defects; Treatment Outcome; Young Adult | 2012 |
The effects of different therapeutic modalities on cardiovascular risk factors in women with polycystıc ovary syndrome: A randomızed controlled study.
Topics: Adult; Androstenes; Apolipoproteins B; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Drug Therapy, Combination; Ethinyl Estradiol; Female; Homocysteine; Humans; Hypoglycemic Agents; Insulin Resistance; Metabolic Syndrome; Metformin; Mineralocorticoid Receptor Antagonists; Peptide Fragments; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Reproductive Control Agents; Risk Factors; Young Adult | 2018 |
2 other study(ies) available for homocysteine and drospirenone
Article | Year |
---|---|
Systemic sclerosis following oral contraception.
Topics: Adult; Androstenes; Antibodies, Antinuclear; Biomarkers; Centromere; Diagnosis, Differential; Female; Follow-Up Studies; Homocysteine; Humans; Menstruation Disturbances; Microscopic Angioscopy; Mineralocorticoid Receptor Antagonists; Progesterone Congeners; Scleroderma, Systemic | 2005 |
Drospirenone and cardiovascular risk in lean and obese polycystic ovary syndrome patients: a pilot study.
Topics: Adolescent; Adult; Androstenes; Brachial Artery; Cardiovascular Diseases; Contraceptives, Oral; Endothelin-1; Female; Homocysteine; Humans; Insulin; Insulin Resistance; Leptin; Mineralocorticoid Receptor Antagonists; Obesity; Pilot Projects; Polycystic Ovary Syndrome | 2010 |